Discover 1,461 paid clinical trials in Renton, Washington. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,461
Clinical Trial of Upfront Haploidentical or Unrelated Donor BMT to Restore Normal Hematopoiesis in Aplastic Anemia
for
Severe Aplastic Anemia
Location: Seattle WA, Salt Lake City UT, Stanford CA,
Sponsor: Medical College of Wisconsin
Sex: All
Age: 3 - 70+
Code: NCT06517641
Phase 2, Recruiting
Study of ECI830 Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast Cancer and in Patients With Other Advanced Solid Tumors
for
Advanced HR+/HER2- Breast Cancer,
Location: Seattle WA, Los Angeles CA, St Louis MO, Houston TX,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 18 - 70+
Code: NCT06726148
Phase 1, Phase 2, Recruiting
Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract Cancer
for
Renal Pelvis and Ureter Urothelial Carcinoma
Location: Seattle WA, Nampa ID, Palo Alto CA, Kingman AZ,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT04628767
Phase 2, Phase 3, Recruiting
Phase 1b/2a Randomized Double-blind Study to Investigate Safety Tolerability PK PD Preliminary Efficacy of Oral Administration of SNIPR001 in Patients With Hematologic Malignancy Scheduled for Allogeneic Hematopoietic Stem-Cell Transplant Receiving FQ Prophylaxis & Harboring FQR Ecoli Pre-Transplant
for
E Coli Infections, Allogenic Transplant Patients
Location: Seattle WA, San Francisco CA, Duarte CA, Minneapolis MN,
Sponsor: SNIPR Biome Aps.
Sex: All
Age: 18+
Code: NCT06938867
Phase 1, Phase 2, Recruiting
Triptorelin for the Prevention of Ovarian Damage in Adolescents and Young Adults With Cancer
Location: Seattle WA, Sacramento CA, Denver CO, Houston TX,
Sponsor: CERo Therapeutics Holdings, Inc.
Sex: All
Age: 18 - 70+
Code: NCT06834282
Phase 1, Recruiting
211At-BC8-B10 Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory High-Risk Acute Leukemia or Myelodysplastic Syndrome
for
Acute Lymphoblastic Leukemia in Remission,
Location: Seattle WA
Sponsor: Fred Hutchinson Cancer Center
Sex: All
Age: 18 - 70+
Code: NCT03670966
Phase 1, Phase 2, Recruiting
MAGIC Ruxolitinib for aGVHD
for
Acute Graft-versus-host Disease,
Location: Seattle WA, Duarte CA, Rochester MN, Fairway KS,
Sponsor: John Levine
Sex: All
Age: 18+
Code: NCT06936566
Phase 2, Recruiting
Type 1 Diabetes Impacts of Semaglutide on Cardiovascular Outcomes
for
Diabetes Mellitus, Type 1
Location: Seattle WA, Aurora CO
Sponsor: University of Colorado, Denver
Sex: All
Age: 18 - 49
Code: NCT05819138
Phase 3, Recruiting
ADAPT Study: Assessing Diet, Appetite and Physiology Throughout Weight Loss Study)
METabolic MODulation to Enhance Insulin Sensitivity and Mitochondrial Function in Type 1 Diabetes (MetMod-T1D)
for
Type 1 Diabetes (T1D), Metabolic Diseases,
Location: Seattle WA
Sponsor: University of Washington
Sex: All
Age: 18 - 69
Code: NCT07699380
Phase 2, Recruiting
Study of the Theranostic Pair RYZ811 (Diagnostic) and RYZ801 (Therapeutic) to Identify and Treat Subjects With GPC3+ (Glypican-3) Unresectable HCC
for
Hepatocellular Carcinoma (HCC)
Location: Seattle WA, Orange CA, Phoenix AZ, Omaha NE,
Sponsor: RayzeBio, Inc.
Sex: All
Age: 18+
Code: NCT06726161
Phase 1, Phase 2, Recruiting
A Study to Evaluate the Adverse Events, and Efficacy of Intravenous (IV) of Telisotuzumab Adizutecan in Combination With IV Oxaliplatin, Fluorouracil, Folinic Acid/Leucovorin, Bevacizumab, Panitumumab in Adult Participants With Metastatic Colorectal Cancer
for
Metastatic Colorectal Cancer
Location: Seattle WA, Calgary, Edmonton, Duarte CA,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT06820463
Phase 2, Recruiting
Study of Momelotinib in Combination With Luspatercept in Participants With Transfusion Dependent Myelofibrosis
for
Primary Myelofibrosis,
Location: Seattle WA, Vancouver, Houston TX, Ann Arbor MI,
Sponsor: GlaxoSmithKline
Sex: All
Age: 18+
Code: NCT06517875
Phase 2, Recruiting
Tolerability Study of Trichostatin A In Subjects With Relapsed or Refractory Hematologic Malignancies
for
Relapsed or Refractory Hematologic Malignancies
Location: Seattle WA, Fairway KS, Lafayette IN, Washington DC,
Sponsor: Vanda Pharmaceuticals
Sex: All
Age: 18+
Code: NCT03838926
Phase 1, Recruiting
Study to Evaluate Safety, Efficacy and Pharmacokinetics (PK) of a Modified Regimen of Ublituximab
for
Relapsing Multiple Sclerosis
Location: Seattle WA, Kirkland WA, Spokane WA, Salt Lake City UT,
Sponsor: TG Therapeutics, Inc.
Sex: All
Age: 18 - 65
Code: NCT05877963
Phase 3, Recruiting
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations